Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07128368

Mechanisms of Resistance Exercise Training for Improved Muscle Insulin Sensitivity

To uncover the underlying mechanisms of resistance exercise training benefits on glucose metabolism and insulin sensitivity in muscle.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Age range

30 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mayo Clinic

Rochester, Minnesota, 55905, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Sedentary (≤30min of physical activity on ≤1 day/week)
  • Weight stable for ≥3 months prior to study

Exclusion criteria

  • Active coronary artery disease or heart failure.
  • Participation in a structured exercise program > 1 day/week.
  • A known medical condition that in the judgment of the investigator might interfere with the completion of the protocol such as the following examples:
  • Abnormal liver function test results (Transaminase >2 times the upper limit of normal)
  • Abnormal renal function test results (calculated GFR <60 mL/min/1.73m2); If on antihypertensive, thyroid, anti-depressant or lipid lowering medication, lack of stability on the medication for the past 2 months prior to enrollment in the study
  • Uncontrolled thyroid disease (TSH undetectable or >10 mlU/L); testing required within three months prior to admission for subjects with a goiter, positive antibodies, or who are on thyroid hormone replacement, and within one year otherwise
  • Abuse of alcohol or recreational drugs
  • Active tobacco usage
  • Infectious process not anticipated to resolve prior to study procedures (e.g. meningitis, pneumonia, osteomyelitis).
  • Uncontrolled arterial hypertension (Resting diastolic blood pressure >90 mmHg and/or systolic blood pressure >160 mmHg) at the time of screening.
  • A recent injury to body or limb, muscular disorder, use of any medication, any carcinogenic disease, or other significant medical disorder if that injury, medication or disease in the judgment of the investigator will affect the completion of the protocol
  • Active pregnancy
  • Menopause (defined as absence of menstruation for 12 consecutive months)
  • Restrictions on Use of Other Drugs or Treatments:
  • Any other medication believed to be a contraindication to the subject's participation.

Treatment and study plan

Resistance Exercise Training

Other

Participants will undergo resistance exercise training 3 days a week for approximately 1 hour each day for 8 weeks.

Primary outcomes

  1. Change in muscle protein synthesis

    Time frame: Baseline; 8 weeks

    Rate of insulin-stimulated synthesis of individual proteins

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Registry information

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Aug 18, 2025
Registry last updated
Dec 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.